Russian scientists develop revolutionary drugs for cancer, HIV and tuberculosis

Print 13 August 2013
Marchmont Innovation News

Russian scientists are developing three types of next gen vaccines that might evolve into the revolutionary drugs for cancer, HIV and tuberculosis, Informing.ru  reported , citing Vladimir Uiba, the director of Russia’s Federal Agency for Medicine and Biology. 

The vaccines are currently undergoing preclinical trials, Mr. Uiba said. 

According to the Agency director, he expects clinical trial testing to start in two years’ time. He underscored that “high efficacy” has been found in all the three drug candidates. 

In February 2010, the Federal Agency for Medicine and Biology entered a cooperation relationship with Rusnano, Russia’s largest nanotech company. Rusnano CEO Anatoly Chubais then said that the agreement between the two partners would enable “a true breakthrough in innovation medicine.”

Source

Return